2022 News Releases

NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

• December 28, 2022

Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health

• December 14, 2022

Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer

• October 27, 2022

Monica Bertagnolli begins work as 16th director of the National Cancer Institute

• October 3, 2022

A healthy lifestyle may help former smokers lower their risk of death from all causes

• September 22, 2022

NCI study of tea drinkers in the UK suggests health benefits from black tea

• August 29, 2022

Many types of leisure time activity may lower risk of death for older adults

• August 24, 2022

NCI awards $23 million to establish centers of excellence to study telehealth for cancer care

• August 18, 2022

Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors

• July 14, 2022

COVID-19 was third leading cause of death in the United States in both 2020 and 2021

• July 5, 2022

Four multinational, interdisciplinary teams selected to address major challenges in cancer

• June 16, 2022

In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half

• June 15, 2022

Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups

• May 19, 2022

Uterine cancer deaths are rising in the United States, and are highest among Black women

• May 5, 2022

Norman Sharpless steps down as director of the National Cancer Institute

• April 4, 2022

NCI launches program to offer molecular characterization of childhood cancers

• March 21, 2022

Gene expression profile could enable rapid identification of anti-tumor immune cells for personalized immunotherapy

• February 3, 2022

NCI study advances personalized immunotherapy for metastatic breast cancer

• February 1, 2022